TJP1 and cancer: EV-miR-103 from HCC cells promotes endothelial permeability and transendothelial invasion by targeting VE-Cadherin, p120 and ZO-1, thereby contributing to vascular permeability in tumor, cancer cell dissemination into the circulation and metastases in liver and lung [174].